Glycemic Markers Beyond HbA1c

Glycemic Markers Beyond HbA1c

Dr. Yehuda Handelsman of the Metabolic Institute of America recently discussed the limitations of HbA1c as a glycemic indicator. He concluded that HbA1c “is not the most accurate measure for patients with severe kidney disease, sickle cell anemia, [and] various blood diseases.” Although continuous glucose monitoring (CGM) is also a suggested measure of diabetes outcomes, Dr. Handelsman points out that CGM is not available for many type 2 diabetics. Therefore, he proposed measuring fructosamine, glycated albumin, or advanced glycation end-products (AGEs) to better monitor type 2 diabetes.

Source: Contact: Kajal Bains

Corporate Communications Associate

Epinex Diagnostics, Inc.

#GlycatedAlbumin #glycatedalbumin #glycatedhemoglobin #HBA1C

Must Read